In the meantime, well continue to fight for patients every single day: helping ensure continuity of care for those already on GLP-1s and enabling new patients to start the most effective treatment available.
Summary: GLP-1 receptor agonists do not directly cause sweating, but some patients report changes in perspiration patterns due to indirect factors such as gastrointestinal side effects, hypoglycaemia when combined with other diabetes medications, or autonomic responses to nausea
This is frequently caused by your bodys inability to maintain enough energy levels
A small number of users report mild appetite reduction
Shikonin (SHK) is a bioactive natural naphthoquinone isolated from the roots of Lithospermum erythrorhizon, which has demonstrated good bioactivity in cancer therapy and anti-inflammation and wound healing (Guo et al., 2019)
What are clinical trials and studies